Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Elizabeth J. Sullivan"'
1
Akademický článek
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light.
Autor: Izabela K Ragan, Lindsay M Hartson, Elizabeth J Sullivan, Richard A Bowen, Raymond P Goodrich
Publikováno v: PLoS ONE, Vol 18, Iss 1, p e0278862 (2023)
BackgroundMonkeypox virus has recently emerged from endemic foci in Africa and, since October 20, 2022, more than 73,000 human infections have been reported by the CDC from over 100 countries that historically have not reported monkeypox cases. The d
Externí odkaz: https://doaj.org/article/7fb8fd91c81445c8a7806f51b670f725
Zobrazit plný text záznamu
5
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
Autor: Elizabeth J. Sullivan, Theodore J. Lampidis, Huaping Liu, Metin Kurtoglu, Randall Brenneman
Publikováno v: Cancer chemotherapy and pharmacology. 73(2)
Although cisplatin is the drug of choice in treating lung cancer patients, relapse and resistance is a common drawback to its clinical effectiveness. Based on cisplatin's reported ability to interfere with numerous cellular components, including mito
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48581da39942a7dcdb8ba171250cef66
https://pubmed.ncbi.nlm.nih.gov/24352250
Zobrazit plný text záznamu
6
The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells
Autor: Niramol Savaraj, Chunjing Wu, George Theodoropoulos, Lynn G. Feun, Macus Tien Kuo, Theodore J. Lampidis, Min You, Medhi Wangpaichitr, Elizabeth J. Sullivan
Publikováno v: Molecular cancer therapeutics. 11(3)
Elimination of cisplatin-resistant lung cancer cells remains a major obstacle. We have shown that cisplatin-resistant tumors have higher reactive oxygen species (ROS) levels and can be exploited for targeted therapy. Here, we show that increased secr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::def5ec93f6ffb1922f3af17d64e07a22
https://pubmed.ncbi.nlm.nih.gov/22248473
Zobrazit plný text záznamu
7
Abstract 4087: Metabolic changes associated with acquired cisplatin resistance
Autor: Elizabeth J. Sullivan, Niramol Savaraj, Metin Kurtoglu, Medhi Wangpaichitr, Theodore J. Lampidis
Publikováno v: Cancer Research. 71:4087-4087
Although cisplatin is the drug of choice in treating lung cancer patients, acquired resistance appears to be a common and serious drawback to its effectiveness in the clinic. Using two pairs of cisplatin sensitive and resistant lung cancer cell lines
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43ef18ea764f80b5ce7cd7658ec146f0
https://doi.org/10.1158/1538-7445.am2011-4087
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje